Keyphrases
Ciprofloxacin
100%
Apoptosis
79%
Colorectal Cancer
77%
Gemcitabine
75%
Mitochondria
54%
Bladder Cancer Cells
52%
Induced Apoptosis
51%
Head-and-neck Cancer
50%
Nonclinical
50%
Nonoperative Management
50%
Complete Response
50%
Circumferential Resection Margin
50%
Human Breast Cancer Cells
50%
Indole-3-carbinol
50%
Molecular Effects
50%
Overall Survival
42%
Chemotherapy
39%
Pathologic
39%
P21Cip1
39%
B-cell Lymphoma 2 (Bcl-2)
37%
Apoptotic Cell Death
37%
Cisplatin
36%
Clinical Complete Response
35%
Cell Cycle Arrest
35%
Cell Growth
35%
Systemic Therapy
33%
Pancreatic Cancer
32%
Cell Growth Inhibition
30%
Breast Cancer Cells
30%
Prostate Cancer Cells
29%
Hormone-sensitive Prostate Cancer
29%
Clinical Trials
28%
Protein Kinase
28%
Adjuvant Therapy
28%
Prostate Cancer
28%
Potentiation
28%
Paclitaxel
27%
G2-M Cell Cycle Arrest
27%
5-fluorouracil (5-FU)
27%
Cancer Cell Growth
26%
Gastrointestinal Cancer
25%
Treatment Refractory
25%
Pregnant Women
25%
Dose Escalation
25%
Cancer Screening
25%
Genetic Testing
25%
Medical Education
25%
Advanced Treatment
25%
Investigational Drugs
25%
Cancer Prevention
25%
Medicine and Dentistry
Rectum Cancer
66%
Diseases
58%
Programmed Cell Death
56%
Cancer Cell
55%
Surgical Margin
50%
Immunotherapy
50%
Squamous Cell Carcinoma
50%
Fluorouracil
45%
Breast Cancer
35%
Malignant Neoplasm
34%
Cisplatin
33%
Systemic Therapy
32%
Overall Survival
31%
Epithelial Cell
28%
Adjuvant Therapy
27%
Mitochondrion
27%
Radiation Therapy
26%
Gastrointestinal Cancer
25%
Metastatic Colorectal Cancer
25%
Ciprofloxacin
25%
Prostate Specific Antigen
25%
Indole-3-Carbinol
25%
Molecularly Targeted Therapy
25%
Prostate Cancer
25%
Bryostatin 1
25%
Protein Kinase C
25%
Soft Tissue Sarcoma
25%
Bladder Cancer
25%
Sensitization
25%
Mantle Cell Lymphoma
25%
Gemcitabine
25%
Colon Carcinoma
25%
Genetic Screening
25%
Cancer Prevention
25%
Head and Neck Cancer
25%
Cancer Pathobiology
25%
Cancer Screening
25%
Neoplasm
23%
Distant Metastasis Free Survival
21%
Consolidation Chemotherapy
21%
Magnetic Resonance Imaging
21%
Capecitabine
20%
Chemoradiotherapy
18%
Anal Cancer
18%
Minoxidil
14%
Clinical Trial
13%
Folinic Acid
12%
Systematic Review
12%
Clinician
12%
Cyclosporine
10%
Pharmacology, Toxicology and Pharmaceutical Science
Ciprofloxacin
100%
Diseases
86%
Gemcitabine
75%
Prostate Cancer
75%
Breast Cancer
75%
Paclitaxel
55%
Pancreas Cancer
50%
Clinical Trial
38%
Bladder Cancer
37%
Neoplasm
30%
Protein Kinase C
28%
Cancer Growth
26%
Investigational Drug
25%
Pembrolizumab
25%
Defactinib
25%
Head and Neck Cancer
25%
Bryostatin 1
25%
Flavopiridol
25%
Prostate Specific Antigen
25%
Gastrointestinal Stromal Tumor
25%
Imatinib
25%
Etoposide
25%
3 Indolemethanol
25%
Mantle Cell Lymphoma
25%
Genistein
25%
Transitional Cell Carcinoma
25%
Colon Carcinoma
25%
Chemotherapy
21%
Malignant Neoplasm
20%
Pancreas Adenocarcinoma
19%
Overall Survival
15%
Biliary Tract Cancer
15%
Protein Tyrosine Kinase Inhibitor
15%
Caspase 3
14%
Western Blot
13%
Folinic Acid
12%
Fluorouracil
12%
Estrogen Receptor
10%
Androgen
10%
Progression Free Survival
10%
Sunitinib
10%
Pharmacotherapy
10%
Ciclosporin
10%
Protein P53
9%
Cyclin B
9%
Flow Cytometry
9%
Molecular Marker
9%
Oxaliplatin
8%
Disease Free Survival
8%
Capecitabine
8%